Pharmacogenomic Strategies for Personalised Medicine (PGxPM2025)

Basic Information

Network EP PerMed
Website https://www.eppermed.eu/news-events/news/ep-permed-jtc2025-pre-announcement-pharmacogenomic-strategies-for-personalised-medicine-pgxpm2025/
Aim of the joint call The overall objectives of the JTC2025 will be to - Support research projects in human health on pharmacogenomic strategies for personalised medicine approaches - Encourage and enable interdisciplinary collaborations, i.e. multi-actor research by engaging a range of other relevant disciplines such as pre-clinical and clinical research, bioinformatics/health informatics/data research, ELSA research, implementation research or health economics research connected to the proposed research topic, including end-user perspective analysis to support the implementation of the research outcomes into clinical practice. - Encourage cross-sectorial collaborations, by including the private sector (e.g. SMEs, small and medium-sized enterprises), industry, as well as regulatory/HTA agencies and patient organisations. - Establish participatory research, i.e. active representation of patients or citizens as part of research projects.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 15/12/2024
Deadline Pre-Proposal 18/02/2025 Submitted proposal: n/a
Deadline Full-Proposal 17/06/2025 Submitted proposal: n/a
Evaluation End Date 31/10/2025 Successful proposal: n/a Proposals funded: n/a
Is call co-funded? Yes
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
  • Large Corporations
Participating networks n/a

Organisations Participating

Country Organisation
Austria Austrian Science Fund (FWF)
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Czech Republic Ministry of Health Czech Republic (MZCR)
Denmark Innovation Fund Denmark (Innofond)
Estonia Estonian Science Foundation (ETAG)
Estonia ESTONIAN SOCIAL MINISTRY (SM-EE)
Finland Business Finland (BF)
France National Research Agency (ANR)
Germany German Aerospace Center (DLR)
Germany Saxon State Ministry for science, culture and tourism (SMWK)
Greece General Secretariat for Research and Technology (GSRT)
Hungary National Research, Development and Innovation Office (NKFIH)
Iceland Icelandic Centre for Research (RANNIS)
Ireland Irish Research Council (IRC)
Israel Ministry of Health (CSO-MOH)
Italy Ministry of Health (MOH/MDS)
Italy REGIONAL FOUNDATION FOR BIOMEDICAL RESEARCH (FRRB)
Italy Tuscany Region (TOS)
Latvia Latvian Council of Science (LCS)
Lithuania Research Council of Lithuania (LSC/LMT/RCL)
Luxembourg National Fund for Research (FNR)
Norway Research Council of Norway (RCN)
Poland National Centre for Research and Development (NCBiR)
Portugal COMMISSION FOR COORDINATION AND REGIONAL DEVELOPMENT OF THE CENTER (ccdrc)
Portugal Foundation for Science and Technology (FCT)
Portugal Regional Government of Azores (AZO-REG)
Spain DEPARTMENT OF HEALTH - GOVERNMENT OF CATALONIA (DDS-GDC)
Spain DEPARTMENT OF HEALTH AND CONSUMPTION OF THE GOVERNMENT OF ANDALUCIA (CSCJA)
Spain Government of Navarra (CFN)
Spain Institute of Health Carlos III (ISCIII)
Sweden Swedish Governmental Agency for Innovation Systems (VINNOVA)
Sweden Swedish Research Council (VR/SRC)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)